Cancer/Tumors Clinical Trials

A listing of Cancer/Tumors medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

NEW

Mayo Clinic Cancer Center
Phoenix Arizona 85054

A Phase 2, Prospective Study Of PRM-151 In Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV MF), Or Post-Essential Thrombocythemia MF (Post-ET MF)

California

NEW

Stanford Cancer Institute
Palo Alto California 94304

A Phase 2, Prospective Study Of PRM-151 In Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV MF), Or Post-Essential Thrombocythemia MF (Post-ET MF)

MMG
Duarte California 91010

Finding the right ALK+ lung cancer treatment is your top priority. It’s our top priority too.

MMG
Loma Linda California 92350

Finding the right ALK+ lung cancer treatment is your top priority. It’s our top priority too.

MMG
Stanford California 94305

Finding the right ALK+ lung cancer treatment is your top priority. It’s our top priority too.

Florida

Jupiter Medical Center
Jupiter Florida 33458

Procurement of Human Biospecimens for Research

Jupiter Medical Center
Jupiter Florida 33458

Procurement of Human Biospecimens for Research

Georgia

NEW

Emory University Hospital
Atlanta Georgia 30322

A Phase 2, Prospective Study Of PRM-151 In Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV MF), Or Post-Essential Thrombocythemia MF (Post-ET MF)

Memorial University Medical Center
Savannah Georgia 31404

Alliance A021202: Prospective Randomized Phase II Trial of Pazopanib (NSC # 737754) Versus Placebo in Patients With Progressive Carcinoid Tumors

Memorial University Medical Center
Savannah Georgia 31404

National Oncologic PET Registry (NOPR)

Maryland

NEW

University of Maryland Medical Center
Baltimore Maryland 21201

A Phase 2, Prospective Study Of PRM-151 In Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV MF), Or Post-Essential Thrombocythemia MF (Post-ET MF)

Massachusetts

NEW

Dana-Farber Cancer Institute
Boston Massachusetts 02215

A Phase 2, Prospective Study Of PRM-151 In Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV MF), Or Post-Essential Thrombocythemia MF (Post-ET MF)

Michigan

NEW

University of Michigan
Ann Arbor Michigan 48109

A Phase 2, Prospective Study Of PRM-151 In Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV MF), Or Post-Essential Thrombocythemia MF (Post-ET MF)

New York

NEW

Mount Sinai Medical Center
New York New York 10029

A Phase 2, Prospective Study Of PRM-151 In Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV MF), Or Post-Essential Thrombocythemia MF (Post-ET MF)

NEW

Weill Cornell Medical Center
New York New York 10065

A Phase 2, Prospective Study Of PRM-151 In Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV MF), Or Post-Essential Thrombocythemia MF (Post-ET MF)

MMG
Bronx New York 10467

Finding the right ALK+ lung cancer treatment is your top priority. It’s our top priority too.

North Carolina

NEW

Wake Forest Baptist Health Center
Winston-Salem North Carolina 27157

A Phase 2, Prospective Study Of PRM-151 In Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV MF), Or Post-Essential Thrombocythemia MF (Post-ET MF)

Pennsylvania

MMG
Hershey Pennsylvania 17033

Finding the right ALK+ lung cancer treatment is your top priority. It’s our top priority too.

MMG
Philadelphia Pennsylvania 19111

Finding the right ALK+ lung cancer treatment is your top priority. It’s our top priority too.

South Carolina

MMG
Charleston South Carolina 29425

Finding the right ALK+ lung cancer treatment is your top priority. It’s our top priority too.

Tennessee

NEW

Vanderbilt University Medical Center
Nashville Tennessee 37232

A Phase 2, Prospective Study Of PRM-151 In Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV MF), Or Post-Essential Thrombocythemia MF (Post-ET MF)

MMG
Nashville Tennessee 37232

Finding the right ALK+ lung cancer treatment is your top priority. It’s our top priority too.

Texas

NEW

MD Anderson Cancer Center
Houston Texas 77030

A Phase 2, Prospective Study Of PRM-151 In Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV MF), Or Post-Essential Thrombocythemia MF (Post-ET MF)

West Virginia

MMG
Morgantown West Virginia 26506

Finding the right ALK+ lung cancer treatment is your top priority. It’s our top priority too.

Canada

NEW

The Princess Margaret Cancer Centre
Toronto International M5T2M9

A Phase 2, Prospective Study Of PRM-151 In Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV MF), Or Post-Essential Thrombocythemia MF (Post-ET MF)

NEW

Providence Health Care
Vancouver International V6Z2A5

A Phase 2, Prospective Study Of PRM-151 In Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV MF), Or Post-Essential Thrombocythemia MF (Post-ET MF)

France

NEW

Hospital Saint-Louis
Paris International 75475

A Phase 2, Prospective Study Of PRM-151 In Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV MF), Or Post-Essential Thrombocythemia MF (Post-ET MF)

Germany

NEW

University Medical Center RWTH Aachen
Aachen International D-52074

A Phase 2, Prospective Study Of PRM-151 In Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV MF), Or Post-Essential Thrombocythemia MF (Post-ET MF)

NEW

Johannes Wesling Academic Medical Center
Minden International 32429

A Phase 2, Prospective Study Of PRM-151 In Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV MF), Or Post-Essential Thrombocythemia MF (Post-ET MF)

Israel

NEW

Hadassah Medical Center
Jerusalem International 91120

A Phase 2, Prospective Study Of PRM-151 In Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV MF), Or Post-Essential Thrombocythemia MF (Post-ET MF)

NEW

Meir Medical Center
Kfar Saba International 4428164

A Phase 2, Prospective Study Of PRM-151 In Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV MF), Or Post-Essential Thrombocythemia MF (Post-ET MF)

Italy

NEW

Fondazione IRCCS Policlinico San Matteo
Pavia International 27100

A Phase 2, Prospective Study Of PRM-151 In Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV MF), Or Post-Essential Thrombocythemia MF (Post-ET MF)

NEW

Marche Nord Hospital
Pesaro International 61122

A Phase 2, Prospective Study Of PRM-151 In Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV MF), Or Post-Essential Thrombocythemia MF (Post-ET MF)

Netherlands

NEW

Radboud University Medical Center
Nijmegen International 6525 GA

A Phase 2, Prospective Study Of PRM-151 In Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV MF), Or Post-Essential Thrombocythemia MF (Post-ET MF)

NEW

Erasmus Medical Center
Rotterdam International 3015 CE

A Phase 2, Prospective Study Of PRM-151 In Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV MF), Or Post-Essential Thrombocythemia MF (Post-ET MF)

United Kingdom

NEW

Guy's and St. Thomas' Hospital
London International SE1 3RT

A Phase 2, Prospective Study Of PRM-151 In Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV MF), Or Post-Essential Thrombocythemia MF (Post-ET MF)